Taken together, these findings suggest that the PTENP1/miR-20a/PTEN axis contributes to the malignant behaviors of breast cancer cells, likely through modulation of the PI3K/AKT pathway by PTEN.154. The gene discussed is PTEN; the disease is breast carcinoma.